News

Date: May 19- 22, 2026  Location: Sao Paulo Expo, Brazil   ✧ 85000 PROFESSIONAL VISITS ✧ 1272 EXHIBITORS ✧ 55 COUNTRIES ✧ +400 CONTENT HOURS   The 31st Hospitalar, Latin America’s most iconic healthcare event with 33 years of legacy. Gather industry leaders, entrepreneurs and healthcare experts, explore cutting-edge solutions, latest technologies and market trends. Four days of premium business networking & exclusive opportunities, shaping the future of healthcare across Latin America.  

European Society for Radiotherapy & Oncology Meeting    Stockholm, Sweden (Stockholmsmässan)  15–19 May 2026  Booth No.: C15:71  Expected Attendees: 7,000+   ESTRO 2026 is a premier international congress dedicated to radiotherapy and oncology. Organized by the European Society for Radiotherapy & Oncology, this event brings together clinicians, researchers, physicists, and healthcare professionals to explore advancements in radiation therapy and cancer treatment strategies. The congress fosters interdisciplinary collaboration to enhance cancer care and improve patient outcomes.  

The fully automatic non-PVC soft bag LVP inspection machine integrates high-efficiency image processing technology, proprietary multi-modal data fusion, and advanced deep learning (AI) algorithms. It effectively addresses key industry challenges such as high false rejection rates, low inspection efficiency, and difficulty in detecting micro-particles in soft bag LVP inspection.     By replacing manual visual inspection, the system significantly reduces labor costs while enhancing inspection efficiency, consistency, and overall quality assurance.   The machine enables reliable detection of various defects, including:   • Foreign particles inside the bag    • Bag body defects    • Missing or incorrect printing    It also supports image-based classification, data archiving, and defect analysis tailored to different defect types.     Advanced High-Precision Imaging Technology   The system adopts industry-leading line-scan imaging technology, enabling continuous high-resolution scanning of high-speed moving products.   Combined with a proprietary suspended imaging method, it captures fine image details under both black and white backgrounds, meeting stringent requirements for high-precision inspection in pharmaceutical production lines.     Intelligent and High-Efficiency Image Processing   Powered by a multi-channel architecture, high-speed data transmission, strong computing capability, and deep learning algorithms, the system can process massive image data in real time.   A self-developed linear light source enhances the imaging of small contaminants, ensuring reliable detection of micro-sized foreign particles.   The system integrates multiple advanced technologies, including:   • Dynamic + static dual-recognition mechanisms    • Multi-station image fusion    • Multi-frame differential algorithms      These technologies effectively eliminate interference from shadows, bubbles, and reflections, enabling precise detection of defects and ensuring consistently high inspection accuracy—supporting uninterrupted and stable production.     Inline Linear Design for Seamless Integration   The machine features an inline linear layout, allowing seamless replacement of manual inspection stations with minimal modification cost and maintenance requirements.   Products are conveyed in a horizontal position and inspected during transport, eliminating the need for additional fixtures or stop-and-shoot processes. This ensures:   • High inspection speed    • Stable imaging performance    • Smooth integration into existing production lines    

On January 23, a delegation led by H.E. Dr. Silvia Lutucuta, Minister of Health of the Republic of Angola, visited Shenzhen People’s Hospital (Longhua Branch) for an in-depth inspection and exchange. The delegation was accompanied by representatives from Sinohydro Bureau 11 Co., Ltd. and Cloudbase. The visit focused on China’s modern hospital management practices and the application of advanced medical technologies. Two benchmark facilities jointly developed with SHINVA Medical Instrument Co., Ltd. (SHINVA)—the Intelligent Endoscopy Center and the Central Sterile Supply Department (CSSD)—became key highlights of the visit.   Intelligent Endoscopy Center: Advancing Digitalized Clinical Practice At the Intelligent Endoscopy Center, the delegation experienced SHINVA’s fully integrated digital clinical ecosystem. As a representative project of SHINVA’s smart healthcare solutions, the center demonstrates deep integration of intelligent medical equipment, information management systems, and patient-oriented services. Smart guidance systems and self-service terminals have significantly improved patient flow efficiency, reducing waiting times by approximately 30%. Advanced cleaning, disinfection, and reprocessing equipment, together with comprehensive safety assurance systems, enhance diagnostic accuracy while reducing the workload of medical staff. The SHINVA Intelligent Endoscopy Center Centralized Management Platform enables full-process visualization, real-time data analysis, and refined resource allocation, effectively strengthening patient safety. These capabilities were highly recognized by the visiting delegation.   Modern Central Sterile Supply Department: Strengthening Infection Control The delegation then visited the hospital’s Central Sterile Supply Department to review SHINVA’s professional solutions in hospital infection prevention and control. Operating under standardized and digitalized management principles, the CSSD integrates SHINVA’s high-performance cleaning, disinfection, and sterilization equipment, together with an information-based traceability system, providing a comprehensive intelligent solution covering the entire lifecycle of reusable medical devices—from collection and classification, cleaning and inspection, packaging and sterilization, to storage and sterile distribution. During the visit, the delegation closely examined key technical parameters, international certifications, and operational performance of the cleaning, disinfection, and sterilization equipment. They expressed strong interest in the CSSD’s smart, IoT-enabled infection control model, recognizing it as a practical reference for the modernization of healthcare facilities in Angola.   Strengthening China–Africa Collaboration for Shared Health Development   This visit marked an important international presentation of SHINVA’s advanced products and integrated healthcare solutions. Through on-site demonstrations at the two flagship departments of Shenzhen People’s Hospital (Longhua Branch), SHINVA showcased its practical achievements in empowering hospital departments through digitalization and intelligent technologies.   With its extensive expertise and innovation capabilities in endoscopy clinical support and infection control, SHINVA has laid a solid foundation for future cooperation with Angola in areas such as personnel training and departmental planning and development.   Looking ahead, SHINVA will continue to uphold its mission of “Better Innovation Better Lives”, leveraging leading smart healthcare solutions to support the modernization of healthcare systems worldwide, deepen China–Africa healthcare cooperation, and jointly contribute to the improvement of global public health and well-being.  

The AEEDC Dubai 2026 opened from January 19 to 21, 2026. As one of the world's largest professional dental exhibitions, it attracted over 85,000 attendees from 177 countries, featuring more than 3,900 exhibitors and 5,300 brands. AEEDC provides a platform to explore cutting-edge technologies and trends and serves as a vital bridge for industry exchange, guiding the global development of dental medicine.     Shinva’s Booth Highlights Shinva made a grand appearance with an upgraded booth layout, featuring expanded exhibition space and a diverse range of products. The booth included several functional zones:   ● Comprehensive treatment unit area   ● Dental laboratory products   ● Intraoral scanner experience zone   ● Surgical instruments and consumables   ● Machine room support equipment   ● Maintenance, packaging, and sterilization products   Innovative Solutions on Display The exhibits spanned high-end treatment units, intelligent intraoral scanners, precision surgical instruments, digital imaging equipment, and efficient sterilization systems, providing a one-stop solution for dental healthcare from diagnosis and treatment to infection control.       Strengthening Global Partnerships At AEEDC, Shinva demonstrated its technological expertise and product advantages while strengthening relationships with international clients. Moving forward, we will continue to uphold our spirit of innovation, contributing more Chinese wisdom and strength to the advancement of global dental healthcare.

From November 17 to 20, 2025, the global healthcare community gathered at Messe Düsseldorf as the 57th MEDICA—one of the world’s largest and most influential medical trade fairs—officially opened. MEDICA 2025 brought together more than 5,000 exhibitors from 72 countries and approximately 80,000 visitors. As a leading enterprise in China’s medical device industry, Shinva presented its latest innovations across core business segments, showcasing the strength of China’s medical technology on the world stage. In the Infection Control and Rehabilitation exhibition area, Shinva redefined medical safety and rehabilitation experience with its intelligent solutions. Through dynamic scenario simulations, the company demonstrated its full-process infection control system. In addition, two advanced rehabilitation devices were showcased, both designed with intelligent and user-centered concepts to help patients regain healthy, active lives and bring new momentum to the rehabilitation industry. Shinva’s ring-type linear accelerator model also drew significant attention in the radiotherapy section. The model highlighted Shinva’s strong capabilities in the development of precision radiotherapy equipment. Its innovative design breaks foreign technological monopolies and brings safer, more efficient precision treatment options to cancer patients worldwide. In the Surgical Instruments section, Shinva displayed a comprehensive portfolio of precision-engineered instruments, each crafted with meticulous attention to detail. The newly launched 4K endoscopic system further demonstrated Shinva’s dedication to superior quality and performance, meeting the needs of diverse surgical environments.      The Cleanroom Technology area focused on the intelligent upgrade of operating theaters. Solutions such as the electric operating table and Smart-L series surgical lights showcased Shinva’s commitment to building safer and more efficient surgical environments. A notable highlight was the debut of Shinva’s self-developed IVD product—the SGH Series Fully Automatic Glycated Hemoglobin Analyzer—at MEDICA. Leveraging advanced technological principles, this device offers a new solution for accurate diagnosis of chronic diseases such as diabetes. Its high-efficiency and high-accuracy detection capabilities provide essential support for diabetes management. Guided by the mission of “Advancing Health Through Innovation,” Shinva continues to explore new frontiers in medical technology. The company’s presence at MEDICA 2025 not only demonstrated its technological strength but also marked a significant step toward becoming a central player in the global healthcare ecosystem. Looking ahead, Shinva will continue to drive innovation and contribute more “Chinese strength” to the advancement of global health.

On November 15, 2025, Shinva successfully hosted the Vietnam Pharmaceutical Equipment and Bio-pharma T+EPC Technology Summit in Hanoi. The event focused on core business areas including Bio-pharmas, aseptic assurance, injectables, laboratory animal facilities and equipment, as well as traditional Chinese medicine extraction and separation. More than 50 industry experts from Vietnamese government agencies and leading pharmaceutical companies attended the summit to explore the integration of advanced technologies and industrial collaboration, injecting new momentum into the high-quality development of the regional pharmaceutical sector. Li Chunyang, Chairman of Shinva Medical Chengdu Yingde Bio, delivered a keynote speech on behalf of the organizer, expressing sincere appreciation for the long-standing trust and support from partners.   The summit aimed to build an efficient platform for industry exchange and resource integration, promoting deep alignment between China’s pharmaceutical technologies and the needs of the Southeast Asian market. From a comprehensive perspective that integrates pharmaceutical processes, equipment, and engineering, the event provided end-to-end support for pharmaceutical enterprises across the region. Looking ahead, Shinva will continue to uphold an open and collaborative approach, empowering regional partners to embrace the global trend of pharmaceutical development and contributing to the advancement of global health.

MEDICA 2025   17-20 Nov.2025 Dusseldorf, Germany Stockumer KirchstraBe 61, D-40474 Dùsseldorf, Germany(Postfach 101006, D-40001 Düsseldorf)   See you at Medica 2025!

Recently, SHINVA Pharmaceutical Technology Group, a subsidiary of SHINVA Medical, has achieved CE certification for two flagship products — the VHP Space Sterilizer and the Filling Isolator. This milestone not only reflects the company’s strong product capabilities and compliance with international quality standards, but also paves the way for smoother access to the European market. International Certification Milestone Since the beginning of this year, SHINVA has made remarkable progress in strengthening its global compliance system. Several core products — including the BFS production line, dry heat sterilizer, and ampoule sterilizer — have successfully passed CE and UL certification tests, laying a solid foundation for overseas market expansion. Commitment to Quality as the Lifeline Behind these achievements lies SHINVA’s unwavering commitment to quality. The company has always regarded quality management as the “lifeline” of international trade, continuously improving product reliability and ensuring long-term, sustainable growth in global markets. Global Vision and Continuous Growth Looking ahead, SHINVA will take this achievement as a new starting point to accelerate the internationalization of more core products, align with global standards, and strengthen its localized service networks worldwide — injecting fresh momentum into the company’s high-quality global development.

We're excited to announce that SHINVA will be exhibiting at CPHI Frankfurt 2025 from October 28–30. Let's meet, connect, and shape the future of healthcare together!Booth No.: 9.0B46 Date: 28–30 Oct, 2025 Venue: Messe Frankfurt, Germany  

On the global stage of medical equipment markets, Shinva Medical, as an outstanding representative of state-owned enterprises, actively implements the national “Going Global” strategy through concrete actions. Around the National Day and Mid-Autumn Festival holidays, Shinva Medical's overseas staff established a positive image for Chinese enterprises abroad through continuous, professional installation, inspection, and maintenance services. Service engineer Wang Tao from Shinva Medical's Infection Control Products Division, alongside the international trade team, traveled to Myanmar, Laos, and Vietnam. They completed equipment inspections, installations, and training sessions, facilitating the seamless integration of infection control equipment into international markets. These projects not only set benchmarks for infection control in Southeast Asia but also demonstrated Shinva Medical's capability to empower international trade through expertise and ensure project success with efficiency.   In Thailand, an engineer team led by Huang Qingchao and Luan Zheng from Shinva Medical's Radiotherapy and Diagnosis Division ensured swift equipment installation and commissioning through seamless collaboration, embodying Shinva Medical's commitment to premium service.     At a major pharmaceutical enterprise in distant Morocco, Shinva Medical Pharmaceutical Technology Group service engineer Sun Changsheng worked continuously for 86 days on-site. Overcoming language barriers, cultural differences, and environmental challenges, he ensured every piece of equipment operated efficiently and stably, providing robust support for the plant's production.     At dental facilities in Bangladesh and the Philippines, Li Weilong, a service engineer from Shinva Medical's Dental Technology Division, conducted comprehensive “check-ups” and fine-tuned dental treatment units to ensure optimal performance. Through systematic training, local medical staff significantly improved their operational skills, leading to substantially enhanced treatment efficiency. The combination of stable product performance and professional technical services has earned “Quality Shinva” widespread international recognition, setting a benchmark for Chinese medical equipment going global.     Guided by the principle of “taking responsibility for both products and customers,” Zheng Chen, an engineer from Shinva Operating Room Technology Division, traveled to Bangladesh. Working tirelessly day and night, he installed, calibrated, and demonstrated the teaching functions of the SMart-L series surgical  lights. With exceptional dedication and technical expertise, he ensured optimal equipment functionality and performance, providing hospitals with reliable surgical lighting and enabling high-quality surgical training for physicians. Through his actions, he upheld the gold standard of “Made in China” and state-owned enterprise service, safeguarding the light of life.  

In the field of medical linear accelerators, intelligent O-ring accelerators and traditional C-arm X-ray machines each possess unique advantages and applicable scenarios. As a leading manufacturer of medical equipment, Shinva has consistently dedicated itself to providing diverse, high-quality accelerator products for clinical use, meeting the practical needs of different departments.   Part.1   Intelligent O-ring accelerator: A  Symbol of Efficiency and Safety Shinva's O-ring accelerator stands out in the market for its highly efficient treatment capabilities and exceptional safety. Its ingenious design features a compact beam module. While it does not support direct electron beam extraction, it demonstrates significant advantages in other aspects.   Part.1 Significantly Enhanced Treatment Efficiency: The accelerated rotation speed of the gantry enables 100% image-guided radiotherapy (IGRT), substantially improving treatment precision and efficiency. Hospitals in China using similar accelerator designs (e.g., Halcyon) have achieved records of treating 200 patients per day—a feat difficult to accomplish with traditional C-arm X-ray machines. Part.2 Zero Collision Risk During Treatment:  The enclosed structure of the ring-frame accelerator effectively eliminates collision risks during treatment, ensuring safety. Part.3 Compact Footprint and Reduced Shielding Requirements: Its compact design minimizes space requirements and reduces shielding demands, making it ideal for facilities with limited space. Although Intelligent O-ring On Line ART System slightly lag behind C-arm X-ray machines in treatment field size and positioning convenience, their efficiency and safety make them an ideal choice for many departments. Particularly as a secondary radiotherapy device, they significantly enhance departmental treatment capacity.   Part 2   C-Arm X-ray machines: Comprehensive Functionality,  Wide Applicability Shinva's C-arm X-ray machine is highly favored clinically for its comprehensive functionality and broad applicability. Its open-structure design supports electron beam therapy, making it suitable for treating scars and certain superficial skin tumors, aligning with clinical practice guidelines.     Part.1 Supports Electron Beam Therapy: The C-arm X-ray machine's open structure enables direct electron beam delivery, meeting specific treatment requirements for certain conditions. Part.2 Large Treatment Field and Flexible Positioning:

On August 19, 2025, SHINVA’s independently developed SGH-400 Fully Automated Glycohemoglobin Analyzer was officially awarded NGSP (National Glycohemoglobin Standardization Program) certification, following its IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) certification in July. Achieving recognition from both of the world’s leading standardization organizations marks that SHINVA’s glycohemoglobin testing products have reached the highest international standards in terms of technical performance and result reliability. Dual Certification Ensures Global Comparability NGSP is the most widely adopted standardization program in clinical practice across the United States. Its results are traceable to the reference values of the landmark DCCT study, serving as an important basis for clinical decision-making. The dual certification of SGH-400 by NGSP and IFCC demonstrates that its testing results have reached an international first-class level, ensuring compatibility and comparability with multi-center research data worldwide. Innovated in China, Supporting Elderly Health Screening The SGH-400 Fully Automated Glycohemoglobin Analyzer, developed by SHINVA, adopts the internationally recognized High-Performance Liquid Chromatography (HPLC) method. This ensures highly accurate results while effectively eliminating interference from hemoglobin variants. The analyzer is designed for efficiency, with the capacity to load 80 samples per run and deliver results at a speed of one sample per 60 seconds. It is well-suited for large-scale screening programs, providing comprehensive solutions for elderly diabetes screening in primary care as well as diabetes diagnosis and treatment in tertiary hospitals.

From August 7 to 9, 2025, the 22nd Academic Conference of the Chinese Neurosurgical Society (CNS) was held in Suzhou, hosted by the Chinese Medical Association and CNS, organized by the Jiangsu Medical Association, and co-organized by the First Affiliated Hospital of Soochow University. Shinva featured its latest innovations, including neuroendoscopic imaging systems, high-end German KARLMED Surgical Instruments, domestically produced neurosurgical tools, and electrosurgical devices. Endoscopic Imaging System   Karlmed GmbH Surgical Instruments   SHINVA Neurosurgical Instruments   Electrosurgical Equipment   Exhibition Founded in 1943, Shinva has over 80 years of experience in surgical instrument development. In 1980, the company pioneered China’s first-generation neurosurgical instrument set, supporting the standardization of neurosurgical procedures nationwide.   Today, Shinva offers a comprehensive product portfolio covering all neurosurgical sub-specialties—from delicate cerebrovascular procedures and precise cranial tumor resections to minimally invasive spinal repairs and specialized cranial injury treatment. Combining advanced technology, reliability, and innovation, Shinva empowers surgeons and safeguards patient outcomes, continuing its enduring mission at the forefront of medical progress.

In recent years, with the rapid development of the healthcare industry, accelerating population aging, and increasing public awareness of health, the orthopedic medical field has experienced a steady growth in market demand. Seizing the opportunity presented by this expanding segment, Xinhua Surgical Instruments Co., Ltd., a subsidiary of SHINVA Medical, has actively ventured into the orthopedic field. By leveraging collaborative innovation across industry, academia, and research, the company is continuously advancing the development of surgical instruments for sports medicine and spinal procedures, contributing to the technological upgrade of China-made orthopedic instruments. In the validation of instrument structure and form, SHINVA has introduced 3D printing rapid prototyping technology, creating an efficient design validation loop. Compared to traditional manufacturing processes, this approach significantly reduces the time and cost associated with product design and verification, greatly improving R&D efficiency. In terms of tackling core technological challenges, SHINVA utilizes digital design tools such as 3D modeling and motion simulation to overcome bottlenecks in instrument connection accuracy and control performance. These advancements address the common issue of "free motion" (non-functional stroke) found in similar instruments, resulting in a substantial improvement in tactile feedback and precision control. For the machining of precision components, the company has innovatively designed high-precision custom fixtures and implemented integrated processing with five-axis machining centers. This process ensures the key shape and dimensional parameters of motion-critical parts are completed in a single machining operation, eliminating the cumulative errors associated with multiple clamping processes. This guarantees stable product performance. To date, the company has successfully developed 73 types of orthopedic-related products. These innovations not only fill the company's product gaps in areas such as cartilage transplantation tools for sports medicine and core instruments for unilateral biportal endoscopic spinal surgery but also meet diverse clinical and market needs through a rich product portfolio.

Where Pharma Innovation Meets Smart Manufacturing   Shinva's Booth N3D01  

From May 10 to 14, 2025, President Luiz Inácio Lula da Silva of the Federative Republic of Brazil paid a state visit to China. On May 12, an important cooperation focusing on precision oncology treatment and the upgrading of public health service systems took place in Beijing.     Representatives of relevant enterprises signed a strategic cooperation memorandum with the Brazilian side on the application of innovative technologies in the field of radiation therapy. This milestone moment was witnessed by Brazilian President Lula, Minister of Health Alexandre Padilha, and other government officials.   At the signing ceremony, a radiotherapy device from China became the center of attention. President Lula proactively held a photo of the device and showcased it to the attendees. Reportedly, this is the "Medical Linear Accelerator" developed and manufactured by Shandong Shinva Medical Instrument Co., Ltd., a star product in China's radiation therapy field, known for its advanced technology in precision oncology treatment. President Lula also posted a group photo of the event on his overseas social media account with 13 million followers. By the time of the news report, the post had received over 26,000 likes, demonstrating the high level of attention the cooperation has garnered.     Amid the continuous increase in global cancer cases, cancer prevention and treatment have become a severe challenge faced by the international community. In this context, the cooperation between Chinese enterprises and Brazil is of great significance. The two sides will engage in in-depth collaboration around the innovation of radiation therapy technology and the upgrading of public health service systems. The aim is to enhance Brazil's precision oncology treatment capabilities by introducing advanced equipment and technology, providing better healthcare services to local residents.   This cooperation is not only an important achievement in medical and health exchanges between China and Brazil but also demonstrates China's strength and commitment in the field of high-end medical equipment manufacturing. As the cooperation deepens, it is expected to bring more innovative solutions to the global field of cancer radiation therapy, making a positive contribution to improving the treatment of cancer patients worldwide.